Prevalence and Causes of Discontinuation of Androgen Receptor Inhibitors in Advanced Prostate Cancer Patients and Analysis of Physician Management to Increase Duration of Therapy

To investigate the prevalence and cause of early discontinuation (DC) of androgen receptor inhibitor (ARi) in advanced prostate cancer (PCa) patients. Additionally, to study the effect of changing ARi vs dose reduction on duration of treatment (DOT). A retrospective cohort study of 333 patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 2023-03, Vol.173, p.142-148
Hauptverfasser:	Gangwish, David, Zwaans, Bernadette M.M., Miriani, Paul, Dejoie, Wesley, Ajo, Andrina, Ervin, Connor, Sarazin, Jeff, Hafron, Jason
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Androgen Receptor Antagonists - therapeutic use Duration of Therapy Humans Male Prevalence Prostatic Neoplasms - therapy Prostatic Neoplasms, Castration-Resistant - drug therapy Receptors, Androgen Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!